Join the DDA or

Four medicines added to export blacklist

Algoliptin/metformin; measles, mumps and rubella vaccine; misoprostol; pneumococcal polysaccharide vaccine

November 7th 2019

Tagged: DM Zone news supply shortages

By Ailsa Colquhoun

The Department of Health and Social Care (DHSC) and the Medicines and Healthcare products Regulatory Agency (MHRA) have added four medicines to those which must not be parallel exported from the UK. The restriction on the following four lines were introduced from 00:00am 6 November 2019:

  • Algoliptin/metformin
  • Measles, mumps and rubella vaccine
  • Misoprostol
  • Pneumococcal polysaccharide vaccine

Read the DHSC/MHRA letter to holders of a wholesale dealer licence

Visit the PSNC website to view the latest list of medicines that cannot be parallel exported from the UK (updated 05/11/19)

The list, will continue to be reviewed on an ongoing basis, to include any product that meets the following criteria:

  1. the medicine is required to meet the needs of UK patients;
  2. the medicine is either being parallel exported or is at threat of being parallel exported; and
  3. the export of that medicine is either contributing to, or may contribute to, a shortage of that medicine in the UK.

The list currently includes products such as adrenaline auto-injectors, estradiol, hepatitis B (rDNA) suspension for injection, levonorgestrel and progesterone.

For all the latest news of the 2019 DDA annual conference...

Learn more